AVA Biodefender
AVA Bio Defender is a biotech company focused on creating genetic protection solutions to combat viruses and their mutations. They develop advanced molecular technologies such as siRNA, CRISPR, and lipid nano-particles to create treatments and resistant organisms for both poultry and humans. Their mission is to provide effective solutions against viral mutations, including future variants, with the potential to generate multi-billion dollar income in meat production and pharmaceuticals.
Industries
Nr. of Employees
small (1-50)
AVA Biodefender
Products
Mutation-resistant antiviral platform using nucleic-acid technologies and nanoparticle delivery
A platform approach combining siRNA design, CRISPR-based strategies, and lipid nanoparticle delivery to create antiviral interventions intended to maintain activity against viral mutations and variants.
Mutation-resistant antiviral platform using nucleic-acid technologies and nanoparticle delivery
A platform approach combining siRNA design, CRISPR-based strategies, and lipid nanoparticle delivery to create antiviral interventions intended to maintain activity against viral mutations and variants.
Services
Development program to create poultry with inherited viral resistance using nucleic-acid and genome-editing approaches, intended for deployment at scale in agricultural production.
Preclinical and translational development of siRNA-based therapeutics delivered by lipid nanoparticles for both treatment and prevention of viral infections.
Development program to create poultry with inherited viral resistance using nucleic-acid and genome-editing approaches, intended for deployment at scale in agricultural production.
Preclinical and translational development of siRNA-based therapeutics delivered by lipid nanoparticles for both treatment and prevention of viral infections.
Expertise Areas
- Nucleic-acid therapeutics (siRNA/RNAi)
- Genome editing (CRISPR)
- Nanoparticle drug delivery (LNP)
- Veterinary genetic protection
Key Technologies
- Small interfering RNA (siRNA)
- CRISPR-based genome editing
- Lipid nanoparticle (LNP) delivery
- RNA interference (RNAi)